Concepedia

Ji Li

JL

Statistics

Publications

4

Citations

106

H-Index

4

Active since

2015

Affiliations

China Medical University(Current)

Ji Li is an author at China Medical University specializing in medicine, oncology, and molecular oncology.

Publications per year

2015–2023

4

Publications

4

Apatinib, a Novel Tyrosine Kinase Inhibitor, Promotes ROS-Dependent Apoptosis and Autophagy via the Nrf2/HO-1 Pathway in Ovarian Cancer Cells

Xiaodan Sun, Ji Li, Yizhuo Li et al. · Oxidative Medicine and Cellular Longevity · 2020 · 44 citations · Full text

Medicine, Oncology, Pharmacology +17

SIRT4 enhances the sensitivity of ER‐positive breast cancer to tamoxifen by inhibiting the IL‐6/STAT3 signal pathway

Jilin Xing, Ji Li, Lin Fu et al. · Cancer Medicine · 2019 · 37 citations · Full text

Medicine, Molecular Biology, Oncology +15

RUNX1 promotes proliferation and migration in non‐small cell lung cancer cell lines via the mTOR pathway

Huan Ma, Siyu Jiang, Yinan Yuan et al. · The FASEB Journal · 2023 · 15 citations · Full text

Medicine, Molecular Biology, Oncology +17

Sensitive, quantitative, and high-throughput detection of angiogenic markers using shape-coded hydrogel microparticles

Mohammad Ali Al-Ameen, Ji Li, David G. Beer et al. · The Analyst · 2015 · 10 citations

Engineering, Bioengineering, Biomedical Engineering +16

1–4 of 4